COMET | Jotup

BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES

Retrieved on:

Thursday, March 28, 2024

Health, COMET, Drug discovery, Partnership, Research, Bio-Techne, Disease, Diagnosis, Workflow, Nikon Instruments, Microscope

MINNEAPOLIS, March 28, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce that Lunaphore , part of Bio-Techne's Spatial Biology Division, is partnering with Nikon Instruments Inc. (Nikon) to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.

Key Points:

MINNEAPOLIS, March 28, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) is pleased to announce that Lunaphore , part of Bio-Techne's Spatial Biology Division, is partnering with Nikon Instruments Inc. (Nikon) to expand access to spatial biology services with the COMET™ platform for US-based biotech, pharma, and academic customers.
Together, Lunaphore and the Nikon BioImaging Lab will be able to leverage their complementary expertise in microscopy-based imaging and analysis to bring COMET technology and spatial biology to the greater scientific community.
Researchers and clinicians can leverage the universal end-to-end product suite to unlock the full potential of spatial biology for their research objectives.
"Spatial biology is a dynamic area of innovation that will shed new light on healthcare and further our understanding of human disease and health."

SMX Announces Joint Venture with Fusion Technology

Retrieved on:

Thursday, February 29, 2024

NASA, ITES, Partnership, Small business, Growth, JV, COMET, Federation

The joint venture will provide both member companies with new opportunities across the Federal Government.

Key Points:

The joint venture will provide both member companies with new opportunities across the Federal Government.
As a joint venture, it is positioned for upcoming strategic GWACs including NASA SEWP, ITES 4S, OASIS+, and COMET.
SMX and Fusion will collaborate on their shared capabilities of cloud migration and integration, advanced infrastructure, life cycle support services, IT operation and maintenance, to better support our clients’ mission success.
This agreement also positions Fusion for new growth opportunities in cloud, data analytics, and digital transformation.

BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS

Retrieved on:

Monday, January 29, 2024

Patient, Research, Bio-Techne, Bladder cancer, Mass meeting, RNA, Poster, Workflow, Protein, Biomarker, Data analysis, Messenger, COMET, Publication, ACD, Vaccine

MINNEAPOLIS, Jan. 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow. Optimized for same-slide detection of protein and RNA biomarkers with unparalleled sensitivity and tissue morphology, the newly developed RNAscope spatial multiomics workflow is compatible with both manual and automated assays. ACD's novel protease-free RNAscope workflow is incorporated in Bio-Techne's recently announced best-in-class multiomics application on Lunaphore's COMET platform.

Key Points:

Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using industry-leading RNAscope™ technology.
MINNEAPOLIS, Jan. 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD) , a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.
Optimized for same-slide detection of protein and RNA biomarkers with unparalleled sensitivity and tissue morphology, the newly developed RNAscope spatial multiomics workflow is compatible with both manual and automated assays.
ACD's novel protease-free RNAscope workflow is incorporated in Bio-Techne's recently announced best-in-class multiomics application on Lunaphore's COMET platform.

LUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH WITH THE LAUNCH OF THE FIRST FULLY AUTOMATED, SAME-SECTION, HYPERPLEX MULTIOMICS APPLICATION

Retrieved on:

Thursday, January 25, 2024

Research, IHC, Mass meeting, RNA, Workflow, Drug development, Antibody, COMET, ACD, Medical imaging

MINNEAPOLIS, Jan. 25, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD) , will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

Key Points:

MINNEAPOLIS, Jan. 25, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD) , will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.
"Combining ACD's leading RNA detection technology with Lunaphore's fully automated high-throughput protein detection capabilities on the COMET system enables a best-in-class multiomics spatial biology solution," commented Kim Kelderman, Bio-Techne's Chief Operating Officer.
With this cutting-edge application, we continue to lead the way and shape the future of the spatial biology market."
To book a meeting or find out more about Lunaphore and ACD's presence at the conference, please visit Lunaphore's website.

COMET Highlights "4 for 10" Gut Health Trends for 2024

Retrieved on:

Thursday, January 11, 2024

Drink, Woman, Food, Life, Menopause, Pregnancy, COMET, Millennials, Appetite, Dietary supplement

SCHAUMBURG, Ill., Jan. 11, 2024 /PRNewswire/ -- COMET, the manufacturer of Arrabina™ prebiotic dietary fibers, has just released its trend predictions that highlight the most robust opportunities for microbiome-enhancing foods, beverages, and supplements in the year ahead.

Key Points:

"We've looked at all aspects of the target biotic consumer including what health motivators are driving them right now, generational and gender differences and what they see as perceived value."
"Interestingly, this year's microbiome predictions have more to do with physical and social trends than they do with gut health, and this is a true sign of the times.
Below are topline details from COMET's four Macro Market Trends and a bit about what that means for the biotics industry.
Reach out to learn more about directions that help uplift slowing sales in the supplement industry.

LUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP INNOVATIVE AI-BASED ASSAY DEVELOPMENT TOOLS

Retrieved on:

Thursday, December 14, 2023

Research, Spatial, Health, COMET, SIB, AI, Bio-Techne, Medical imaging

MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore , a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics , have been awarded Innosuisse funding for an innovation project.

Key Points:

MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore , a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics , have been awarded Innosuisse funding for an innovation project.
The collaboration aims to develop novel AI-based assay development tools for spatial biology on Lunaphore's COMET™ to further accelerate the adoption of multiplex sequential immunofluorescence (seqIF™) technology in research.
Spatial biology utilizes detailed tissue analysis and intracellular interactions to enable profound insights in cancer biology, immuno-oncology, and other research fields.
However, technical hurdles still stand in the way of spatial biology technologies entering clinics and becoming guiding tools for personalized therapies.

Comtech Receives $20.0 Million Order from Spectra Group to Service Multiple NATO and European Regional Orders for Next Generation Troposcatter Systems

Retrieved on:

Thursday, November 9, 2023

The order will allow Spectra Group, the appointed regional distributor of Comtech’s Compact Over-the-Horizon Transportable Terminal (COMET), to service multiple orders already received, and several expected follow-on orders from undisclosed customers in the NATO and European regions.

Key Points:

The order will allow Spectra Group, the appointed regional distributor of Comtech’s Compact Over-the-Horizon Transportable Terminal (COMET), to service multiple orders already received, and several expected follow-on orders from undisclosed customers in the NATO and European regions.
“Through this order from Spectra Group, Comtech is helping expand network agnostic, secure, and interoperable BLOS communications capabilities for our NATO and EU regional partners,” said Ken Peterman, President and CEO, Comtech.
In September 2023, Spectra Group announced the receipt of a $8.0 million order from UK MoD to equip 3 (UK) Division with Comtech’s COMET systems.
Spectra Group is now close to receiving additional orders for large quantities of Comtech’s COMET systems from other key NATO and European regional customers.

Unbabel Releases New Open-Source Large Language Model, The First LLM Fine Tuned to Predict Translation Quality

Retrieved on:

Tuesday, September 26, 2023

LLM, MT, Language, XXL, COMET, SAN, WMT, Translation, Growth, Entrepreneurship, AI, Film industry, Unbabel

SAN FRANCISCO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Unbabel, the AI-powered Language Operations (LangOps) platform that helps businesses deliver multilingual customer experience at scale, today announced the public release of its new open-source Large Language Model (LLM), CometKiwi XL and XXL, specially designed to predict translation quality. As the first LLM fine tuned for translation quality, CometKiwi offers exceptional performance and unprecedented quality estimation capabilities – contributing to increasingly accurate translations and improved cost savings while supporting global expansion.

Key Points:

As the first LLM fine tuned for translation quality, CometKiwi offers exceptional performance and unprecedented quality estimation capabilities – contributing to increasingly accurate translations and improved cost savings while supporting global expansion.
We firmly believe that CometKiwi will make a significant contribution to the growth and innovation of the machine translation field as a whole.
Even with its recent rapid advancements, AI translation is not always 100% accurate, especially in complex use cases.
Additionally, with the explosion of machine translation products trained on different data sets, some models perform better than others for certain use cases.

BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION

Retrieved on:

Monday, July 10, 2023

Marketing, Risk, Biotechnology, Research, COMET, Acquisition, Security (finance), Annual report, Medical imaging

MINNEAPOLIS, July 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced it has completed the acquisition of Lunaphore Technologies SA, a leading developer of fully automated spatial biology solutions.

Key Points:

MINNEAPOLIS, July 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced it has completed the acquisition of Lunaphore Technologies SA, a leading developer of fully automated spatial biology solutions.
Bio-Techne and Lunaphore are combining forces to accelerate their spatial biology leadership position in translational and clinical research markets.
Lunaphore also offers LabSat®, an automated tissue staining instrument that offers a 30-minute turn-around time, delivering a much faster and hands-off staining solution compared to manual methods where turnaround times can take several days.
Forward looking statements in this press release include statements regarding our belief about the market applications and impact of our acquisition of Lunaphore, Inc. and our ability to derive advantages from this acquisition as we integrate it into our business.

Comet Announces Return of Comet Fest Fan Festival in 2024

Retrieved on:

Thursday, June 29, 2023

COMET , the top destination on free TV for fans of sci-fi and fantasy entertainment franchises, today announced the return of the Comet Fest fan festival in 2024.

Key Points:

COMET , the top destination on free TV for fans of sci-fi and fantasy entertainment franchises, today announced the return of the Comet Fest fan festival in 2024.
The network’s first annual Comet Fest, which ran June 16-18, 2023, garnered record-setting success for Comet.
Comet Fest drove fan engagement across Comet’s platforms with a surge in ratings delivering an increase of 82% in the time period and thousands of entries into the first ever Comet Fest cosplay and digital contests.
“We expect Comet Fest 2024 to surpass these results as we celebrate the AI android-themed franchises that have inspired the imaginations of fans around the world.”